Drug Company

Jun 28, 2016 at 23:31 | Source:
Standout companies differentiate themselves by way of stock price return over the long term.
Jun 28, 2016 at 13:25 | Source:
Panacea introduces indigenously developed high quality antidiabetic drug, Tenepan (Teneligliptin), for treatment of type 2 diabetes mellitus," says the country's third largest biotechnology company.
Jun 27, 2016 at 20:34 | Source: CNBC-TV18
The High Court has said that these companies are unlikely to take any further price cuts over the WPI which would be under the revision of the national list of essential medicines, reports Ekta Batra of CNBC-TV18.
Jun 24, 2016 at 14:24 | Source: PTI
The company has "received abbreviated new drug application (ANDA) approval from the United States Food and Drug Administration (USFDA) for Donepezil Hydrochloride tablets USP," Unichem Laboratories said in a filing to BSE.
Jun 23, 2016 at 12:32 | Source: PTI
Biocon and Quark Pharmaceuticals also announced the randomisation of the first patient in India in the global Phase II/III study of the new drug candidate, the company said in a statement.
Jun 23, 2016 at 09:32 | Source: PTI
Company's US subsidiary Gavis Pharmaceuticals LLC has received final approvals to market "its Voriconazole tablets, 50 mg & 200 mg and Voriconazole Oral Suspension, 40 mg/mL from the United States Food and Drug Administration (FDA)," Lupin said in a filing to BSE.
Jun 18, 2016 at 10:36 | Source: PTI
"Today patients undergoing anti-HIV treatment have to take a lot of drugs every day. Our preparations will meet the expectations of Russian patients and will solve this problem," Nacimbio CEO Nikolay Semenov said.
Jun 16, 2016 at 15:04 | Source: PTI
In a regulatory filing, the company said after inspection, the FDA has passed an order to suspend manufacturing licences at Mahad unit for 15 days, from July 1 to July 15, 2016.
Jun 14, 2016 at 14:24 | Source: PTI
With these new patents, the company has a total of 23 patents from Canada and 20 patents from Hong Kong, it added.
Jun 13, 2016 at 14:12 | Source: CNBC-TV18
Saumen Chakraborty, CFO of the company told CNBC-TV18 that they hope to commercialise four out of the eight products by FY18. He said all the eight products are expected to have limited competition.
Messages on Drug Company »


Gold Member


Dr Reddys Labs  

The US market continues to drive growth for Dr Reddy`s and other Indian generic drug companies. What if this paradigm changes in the global context? The US drives the growth but we have to diversify our sources of growth even though the relative importance of the US may not change. Emerging markets

8.53 PM Jun 30th 2014

anil patil

Platinum Member


Aurobindo Pharm  

deal details with the stock exchanges showed. Morgan Stanley Asia Singapore, which is a shareholder of Aurobindo Pharma, sold 17,32,500 shares of the drug company for about Rs 670 apiece, valuing the transaction at Rs 116 crore. Morgan Stanley Asia Singapore held 46.16 lakh shares of Aurobindo Pharma

11.48 AM May 31st 2014


Platinum Member


Dishman Pharma  

Dishman Pharma is likely to move to UC after 28.05.2014. This drug company will find support at Rs.125/- on account of excellent results. Your best time to pick up this stock at the bottom fishing zone.

8.43 PM May 26th 2014


New Member



Drug Policy Control Order (DPCO) put a cap on the prices of 348 essential drugs, is likely to impact domestic revenue generation of both homegrown and multinational drug companies in 2014

12.55 PM May 15th 2014


Platinum Member



, according to data tracker Dealogic. Many drug companies have paid down debt taken on during a buying spree in the earlier 2000s and are now generating lots of cash they want to put to work. Prescription drug makers are also attracted to acquisitions because deals can allow them cut costs and scale back

4.02 PM Apr 22nd 2014


New Member


Aurobindo Pharm buy , rather accumulate Auro even at current levels for a 1-2 year timeframe. these US legalities are nothing new to Indian drug companies,happens all the time !

10.06 AM Apr 17th 2014

Web Messenger

Platinum Member


Sun Pharma  

Source:VC Circle - Sun Pharmaceutical Industries Ltd, the country's top drugmaker by market cap, is acquiring Ranbaxy Laboratories Ltd in an all-stock transaction, creating the world's fifth-largest generics drug company and the largest pharma company in India by far

12.10 PM Apr 8th 2014


Platinum Member


Sun Pharma  

Is it patent dispute with Drug company UCB?

9.16 PM Mar 18th 2014


Gold Member


Vivimed Labs  

I am doctor by profession and knows the value of research and upcoming drugs. COMPANY has spent lot of rs in research and next quarter filing new ADNA / molecules which will drive the earning. you see almost 90% of shares are by institutes or large investor.

12.47 PM Mar 18th 2014

Web Messenger

Platinum Member



Source:Calcutta Telegraph News - Mumbai, Feb. 20: Cipla has entered into an agreement with MSD to market the latter’s anti-HIV drug raltegravir in the country. This is the first time that Cipla is entering into a strategic partnership with a multinational drug company. MSD is the trade name

2.10 PM Feb 21st 2014

Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.